| 08.11.2024 14:41 | MXCT | MaxCyte third-quarter profit falls amid surging costs | Alliance |
| 07.11.2024 07:00 | MXCT | Filing of 10Q form | RNS |
| 07.11.2024 07:00 | MXCT | Third Quarter 2024 Financial Results | RNS |
| 06.11.2024 13:43 | MXCT | Exercise of options and PDMR dealing | RNS |
| 04.11.2024 13:23 | MXCT | Total Voting Rights | RNS |
| 31.10.2024 12:05 | MXCT | Upcoming Investor Conferences | Reach |
| 31.10.2024 07:00 | MXCT | Exercise of options and PDMR dealing | RNS |
| 30.10.2024 15:08 | WISE, TLY, PSN | UK earnings, trading statements calendar - next 7 days | Alliance |
| 18.10.2024 09:24 | MXCT | Grant of Options and Restricted Stock Units | RNS |
| 15.10.2024 13:05 | MXCT | MaxCyte Appoints Cynthia Collins to Board | RNS |
| 11.10.2024 13:00 | MXCT | Notice of Results | RNS |
| 10.10.2024 13:05 | MXCT | MaxCyte Appoints Ali Soleymannezhad as CCO | RNS |
| 03.10.2024 09:41 | MXCT | Exercise of options and PDMR dealing | RNS |
| 01.10.2024 09:47 | MXCT | Exercise of options and PDMR dealing | RNS |
| 01.10.2024 07:00 | MXCT | Total Voting Rights | RNS |
| 27.09.2024 16:15 | MXCT | Holding(s) in Company | RNS |
| 27.09.2024 15:29 | MXCT | Holding(s) in Company | RNS |
| 20.09.2024 17:02 | MXCT | Holding(s) in Company | RNS |
| 16.09.2024 10:33 | MXCT | MaxCyte touts strategic platform license deal with Kamau Therapeutics | Alliance |
| 16.09.2024 07:00 | MXCT | TR-1: Notification of major holdings | RNS |
| 16.09.2024 07:00 | MXCT | Signing of Strategic Platform License | RNS |
| 06.09.2024 17:07 | MXCT | Exercise of options and PDMR dealing | RNS |
| 06.09.2024 11:33 | MXCT | Bioprocessing Conference Participation | Reach |
| 03.09.2024 15:38 | MXCT | Total Voting Rights | RNS |
| 29.08.2024 10:06 | MXCT | Exercise of options and PDMR dealing | RNS |
| 07.08.2024 14:10 | MXCT | MaxCyte reaffirms guidance as revenue jumps 24% in first half | Alliance |
| 07.08.2024 07:05 | MXCT | Filing of Form 10-Q | RNS |
| 07.08.2024 07:00 | MXCT | Second Quarter and Half-Year Results | RNS |
| 01.08.2024 16:31 | MXCT | Total Voting Rights | RNS |
| 31.07.2024 07:00 | MXCT | Exercise of options and PDMR dealing | RNS |
| 30.07.2024 13:57 | ZTF, XPP, TPK | UK earnings, trading statements calendar - next 7 days | Alliance |
| 10.07.2024 09:15 | MXCT | Notice of Results | RNS |
| 09.07.2024 09:14 | MXCT | Change of Name of Nominated Adviser and Broker | RNS |
| 03.07.2024 07:00 | MXCT | TR-1: Notification of major holdings | RNS |
| 02.07.2024 07:00 | MXCT | Total Voting Rights | RNS |
| 27.06.2024 14:34 | MXCT | Publication of Annual Report | RNS |
| 14.06.2024 07:00 | MXCT | Grant of Options and Restricted Stock Units | RNS |
| 12.06.2024 07:00 | MXCT | Result of AGM | RNS |
| 11.06.2024 11:10 | MXCT | IN BRIEF: MaxCyte CEO Maher Masoud buys 100,000 shares | Alliance |
| 11.06.2024 07:00 | MXCT | PDMR Dealing | RNS |
| 04.06.2024 14:27 | SHIP, MEX, TGR | UK shareholder meetings calendar - next 7 days | Alliance |
| 03.06.2024 15:22 | MXCT | Total Voting Rights | RNS |
| 29.05.2024 13:05 | MXCT | Participation in Upcoming Investor Conference | RNS |
| 22.05.2024 21:51 | MXCT | IN BRIEF: MaxCyte inks deal with Legend Biotech for tech supply | Alliance |
| 22.05.2024 13:05 | MXCT | Signing of Strategic Platform License | RNS |
| 20.05.2024 07:00 | MXCT | Holding(s) in Company | RNS |
| 14.05.2024 14:55 | MXCT | Holding(s) in Company | RNS |
| 08.05.2024 09:46 | MXCT | MaxCyte shares rise amid double-digit revenue increase | Alliance |
| 08.05.2024 07:05 | MXCT | Filing of Form 10-Q | RNS |
| 08.05.2024 07:00 | MXCT | First Quarter Results | RNS |
| 03.05.2024 09:14 | SHI, NRR, CVSG | LONDON BROKER RATINGS: Jefferies cuts AJ Bell; Deutsche likes ConvaTec | Alliance |
| 03.05.2024 07:00 | MXCT | Notice of AGM | RNS |
| 01.05.2024 17:04 | MXCT | Total Voting Rights | RNS |
| 30.04.2024 14:38 | IWG, MXCT, KOS | UK earnings, trading statements calendar - next 7 days | Alliance |
| 10.04.2024 13:05 | MXCT | Notice of Results | RNS |
| 03.04.2024 07:00 | MXCT | Total Voting Rights and Block Listing Return | RNS |
| 02.04.2024 15:19 | ORCA, CIZ, ANIC | TRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmout | Alliance |
| 02.04.2024 13:05 | MXCT | Signing of Strategic Platform License | RNS |
| 02.04.2024 07:00 | MXCT | Exercise of options and PDMR dealing | RNS |
| 20.03.2024 10:16 | MXCT | Grant of Options, RSUs and PSUs and PDMR Dealing | RNS |
| 20.03.2024 10:05 | MXCT | Grant of Options, RSUs and PSUs and PDMR Dealing | RNS |
| 13.03.2024 11:54 | MXCT | IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25% | Alliance |
| 13.03.2024 07:05 | MXCT | Filing of form 10-K for FY ended December 31, 2023 | RNS |
| 13.03.2024 07:00 | MXCT | Reports Q4 & FY 2023 Financial Results | RNS |
| 06.03.2024 08:58 | MXCT | TR-1: Notification of major holdings | RNS |
| 05.03.2024 20:43 | TMO, THR, OGN | EARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profit | Alliance |
| 05.03.2024 16:06 | TCAP, TIFS, SYNT | UK earnings, trading statements calendar - next 7 days | Alliance |
| 05.03.2024 07:00 | MXCT | Preliminary FY Results & 2024 Guidance | RNS |
| 01.03.2024 17:57 | MXCT | Total Voting Rights | RNS |
| 29.02.2024 09:21 | MXCT | Exercise of options and PDMR dealing | RNS |
| 26.02.2024 07:00 | MXCT | TR-1: Notification of major holdings | RNS |
| 31.01.2024 07:00 | MXCT | Director/PDMR Shareholding | RNS |
| 30.01.2024 14:29 | MXCT | Holding(s) in Company | RNS |
| 30.01.2024 13:58 | MXCT | IN BRIEF: MaxCyte signs licencing deal with cell therapy company Wugen | Alliance |
| 30.01.2024 13:05 | MXCT | Signing of Strategic Platform License | RNS |
